Physician profile
John L Goad
NPI 1588627459
$3,419.36
in general payments reported to CMS, 2019-2025
19 companies · $459 in 2025
The $459 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $211 · 2021: $596 · 2022: $665 · 2023: $562 · 2024: $327 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,348.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $834.45 | 2019-2025 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, General - Balloon Catheters |
| Kestra Medical Technology Services, INC. | $442.36 | 2023-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $397.22 | 2019-2024 | Lifevest |
| Abiomed | $383.25 | 2019-2025 | Impella |
| Cardinal Health 200 LLC | $331.33 | 2019-2021 | |
| Cordis US Corp. | $294.95 | 2021-2022 | |
| Cvrx, INC. | $142.86 | 2024 | Barostim Neo System |
| Abbott Laboratories | $138.14 | 2021 | |
| Philips North America LLC | $84.65 | 2022 | |
| Astellas Pharma US INC | $82.99 | 2019 | |
| Shockwave Medical, INC | $68.84 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $53.42 | 2022-2023 | |
| Medtronic, INC. | $33.71 | 2025 | Linq II |
| Amgen INC. | $33.25 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $31.17 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $19.91 | 2023 | |
| Janssen Pharmaceuticals, INC | $18.13 | 2022 | |
| Teleflex LLC | $15.66 | 2025 | Orsiro Mission |
| Cardiovascular Systems INC. | $13.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Goad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.